Adobe is one of the most attractively priced software stocks in the market right now, while CrowdStrike commands a premium valuation that reflects one of the strongest growth trajectories in cybersecurity.
AST SpaceMobile seeks an FCC extension for 800 MHz satellite testing as the SDA backs a separate spectrum application, highlighting growing defense interest despite recent earnings misses.
What Happened? Shares of online used car auction platform ACV Auctions (NYSE:ACVA) jumped 43.5% in the morning session after Copart and ACV announced a defin...
What Happened? Shares of e-commerce pet food and supplies retailer Chewy (NYSE:CHWY) fell 5.8% in the morning session after JPMorgan analyst Doug Anmuth down...
What Happened? Shares of personal computing and printing company HP (NYSE:HPQ) jumped 8.2% in the morning session after RBC Capital analyst David Paige initi...
What Happened? A number of stocks jumped in the afternoon session after escalating attacks on Middle East shipping corridors and production shut-ins raised c...
What Happened? A number of stocks jumped in the morning session after macroeconomic relief from declining Treasury yields and lower oil prices, coupled with ...
What Happened? Shares of medical technology company Inspire Medical Systems (NYSE:INSP) jumped 7.4% in the morning session after Stifel analyst Jonathan Bloc...
What Happened? A number of stocks jumped in the morning session after macroeconomic relief from declining Treasury yields and lower oil prices, coupled with ...
AMGN stock fell after Novartis' Pelacarsen trial failed, though Amgen's own Olpasiran and Repatha differ in mechanism and results, and analysts have kept price targets largely intact.
Lam Research (NASDAQ:LRCX) said it is prioritizing customer execution, capacity readiness and product-roadmap delivery as semiconductor equipment demand remains strong and customers seek tools sooner than the company can provide them.
During a Goldman Sachs discussion with Senior Equity Analyst Jim
Cheetah Mobile (NYSE:CMCM) said its second-quarter 2026 results reflected a continued shift toward cloud and AI infrastructure services and robotics, even as changes affecting its advertising agency business weighed on profitability.
Total revenue was RMB266.1 million, up 2.7% from the prior quarte
Amgen is profitable and paying a growing dividend, while Revolution Medicines is burning cash to fund what could be one of the most important cancer drug launches in years.
